In the data obtained from the cohort, proteins such as TTR, SRSF10, RPS21, SRP9, DBI, BTF3, GZMK, RO60, STMN1, ENAM and CD59 had significant prognostic value in both the T1DM and MS groups. The gene discussed is SRP9; the disease is myeloid sarcoma.